Regarding the TILs, increased infiltration of FoxP3+ Tregs was associated with improved OS in colorectal, head and neck, and esophageal cancer, whereas in melanoma, lung, cervical, renal, hepatocellular, gastric, and breast cancers, it was linked with shorter OS [27]. This evidence concerns the gene FOXP3 and breast carcinoma.